The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence

Melanoma Research

Volumn 21, Issue 5, 2011, Pages 446-449

  Abbott, Rachel Angharad ^a   Acland, Katharine M ^a   Harries, Mark ^a   O'Doherty, Michael ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

melanoma; positron emission tomography with computed tomography; surveillance

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARM; BREAST CARCINOMA; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CUTANEOUS MALIGNANT MELANOMA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LEG; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SKIN CANCER; THYROID CARCINOMA; TRUNK;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 80052689728     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3283480256     Document Type: Review

References (10)

1. MacKie RM, Hauschild A, Eggermont AMM. Epdemiology of invasive cutaneous melanoma. Ann Oncol 2009; 20 (Suppl 6): vi1-vi7.
2. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648. (Pubitemid 32786276)
3. Ackali C, Zincirkeser S, Erbagcy Z, Ackali A, Halac M, Durak G, Sager S. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT. J Int Med Res 2007; 35:547-553. (Pubitemid 47261118)
4. Krug B, Crott R, Lonneux M, Baurain JF, Pirson AS, Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology 2008; 249:836-844.
5. Strobel K, Dummer R, Husarik DB, lago MP, Hany TF, Steinert HC. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information of detection of metastases. Radiology 2007; 244:566-574. (Pubitemid 47080890)
6. Dicker TJ, Kavanagh GM, Herd RM, Ahmad T, McLaren KM, Chetty U, et al.; Scottish Melanoma Group. A rational approach to melanoma follow up in patients with primary cutaneous melanoma. Br J Dermatol 1999; 140:249-254. (Pubitemid 29111351)
7. Koskivou IO, Seppänen MP, Suominen EA, Minn HRI. Whole body positron emission tomography in follow-up of high risk melanoma. Acta Oncol 2007; 46:685-690. (Pubitemid 46911905)
8. Ngyuen NC, Chaar BT, Osman MM. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT. BMC Med Imag 2007; 7:8.
9. Mansour AA, Kelley MC, Hatmaker AR, Holt GE, Schwartz HS. Verification of musculoskeletal FDG-PET-CT findings performed for melanoma staging. Ann Surg Oncol 2010; 17:1144-1151.
10. Horn J, Lock-Anderson J, Sjøstrand H, Loft A. Routine use of FDG-PET scans in melanoma patients with positive sentinel lymph nodes biopsy. Eur J Nucl Med Mol Imag 2006; 33:887-892. (Pubitemid 44127436)